Squamous cell carcinoma (SCC) is the most common cancer of the equine eye, and is second to equine sarcoid as the most common tumor of the horse overall. 1 Frequently, ocular SCC originates at the limbus, the junction of the sclera and cornea. 2, 3 Tumors at the limbus can spread axially into the cornea and can quickly lead to visual impairment and destruction of the eye (Figs. 1a and 1b) . 4 Other common locations of ocular squamous cell tumor formation include the nictitans (third eyelid) and the upper and lower eyelids. 5 Typically ocular tumors are locally invasive and have a high rate of recurrence (as high as 66.7% in one study) but metastasis is thought to be uncommon with reports ranging from 0 to 18.6%. [6] [7] [8] [9] The etiopathogenesis of ocular SCC is not entirely understood but several factors are thought to be involved. A welldocumented risk factor is exposure to ultraviolet (UV) radiation. In horses, increased longitude, altitude and mean annual solar radiation have been correlated with ocular SCC prevalence. 10 Ultraviolet radiation causes mutations in the tumor-suppressor gene p53, a transcription factor that responds to cellular stresses and regulates expression of other genes involved in cell cycle progression. More than half of all human tumors contain inactive p53 11 and overexpression of p53 protein was detected in equine, bovine and feline ocular SCC. 12 Altered expression leads to uncontrolled cell growth through several mechanisms including altered DNA repair. Only two cytosine-to-thymine transitions (one vulva SCC and one eyelid SCC case) of p53 have been reported in the horse. 13 Other potential contributors to ocular SCC include viral exposure and hormonal regulation. In humans, infection with human papillomavirus is thought to be a risk factor for ocular SCC and in horses, equine papillomavirus type 2 (EcPV2) has been identified as a risk factor for genital SCCs although the role of this virus in ocular SCC is not known. [14] [15] [16] Several studies have shown that geldings (castrated male horses) appear to be more predisposed to ocular SCC than stallions (intact male horses) and females, suggesting that changes in hormones between castrated and sexually intact animals may contribute to disease. 10, 17 Many studies have also identified breed predispositions for ocular SCC indicating genetics as a significant contributor to ocular SCC cancer risk. 2, 3, [8] [9] [10] [18] [19] [20] [21] [22] [23] Among those breeds with the highest occurrence of ocular SCC are the Appaloosa and the American Paint Horse. 20 Both breeds are known for their striking white spotting coat patterns, which often also lack photoprotective pigment in the skin and conjunctiva of the periocular region. Pigment protects against the accumulation of DNA mutations caused by UV exposure as described above. However, with the exception of the single p53 mutant, 13 ocular tumors from horses have yet to be characterized for UV induced DNA mutations. Several studies have also implicated an increased risk of ocular SCC with chestnut coat color and grey coat depigmentation pattern, suggesting that the genes controlling these phenotypes can explain increased incidence in some horse breeds. 17, 18, 20 The chestnut coat color results from a recessive loss of function mutation in the melanocortin 1 receptor (MC1R) gene (genotypically denoted as e/e). 24 MC1R is a G-protein-coupled receptor expressed on the surface of melanocytes that regulates switching from eumelanin, black/ brown pigment, to pheomelanin, red pigment. Thus chestnut horses lack eumelanin production resulting in their red coat color. People with MC1R mutations (red hair and freckling) are generally photosensitive, prone to sunburn when exposed to UV light, and have an increased risk of melanomas tied to UV associated somatic C > T transitions. 25 The gray coat color in horses is a gradual loss of pigment caused by a 4.6 kb duplication in the syntaxin-17 gene (STX17) that depletes melanocyte stem cells and results in pigment loss, which often first occurs around the eyes. 26 This duplication has been associated with an increased risk for melanomas in
horses. The precise role that chestnut and grey coat color phenotypes play in ocular SCC remains to be investigated. While pigmentation difference can develop hypotheses on how genetic factors contribute to ocular SCC risk, relatively little is known about the specific mutations leading to SCC in horses and if genetics can explain the variability in the reoccurrence and metastatic rates observed. The Haflinger breed, developed in Austria and Northern Italy during the late 19th century, appears to be among those breeds overrepresented for this disease. Two retrospective studies indicate that 69% and 26% of limbal SCC affected horses were Haflingers and SCC prevalence is estimated to be 35% in this breed. 2, 3 Furthermore, the mean age of diagnosis is younger in Haflingers suggesting a genetic predisposition. 3 Haflingers are fixed for the chestnut coat color (Fig. 1c) . While variability in the shade of pheomelanin exists, examining a breed fixed for a previously recognized risk factor (e/e) should help to identify other genetic risk factors in this breed. Furthermore, as it is unknown if genetic risks are the same for limbal, nictitans, and upper and lower lids, and as Haflingers are most often reported to have limbal SCC, we chose to limit this initial investigation to limbal SCC. Preliminary pedigree analysis of 15 horses affected with limbal SCC identified a common ancestor among all affected individuals and supported an autosomal recessive mode of inheritance, providing justification for a genetic investigation in this breed. 3 The aim of this study is to evaluate the genetic risk of limbal SCC in Haflingers by expanding the pedigree analysis and employing a genome-wide association study (GWAS) to identify candidate causal risk loci warranting further investigation.
Material and Methods

Animals and phenotyping
Seventy Haflinger horses whose owners gave written consent were included in this study. A complete ocular examination was performed by a board certified veterinary ophthalmologist. The examination included evaluating the adnexa, anterior, and posterior ocular segments of both eyes with a Finoff transilluminator (Heine USA, Dover, NH, USA), slit-lamp biomicroscope (Heine USA), and with direct and indirect ophthalmoscopes (Heine USA). Affected horses showed clinical signs of limbal SCC as evidenced by a growth on the limbus, and/or were confirmed by histopathology report. Unaffected horses were free of any suspicious growth or ocular lesion. For all molecular work, unaffected
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The horse is an important cancer model, as metastasis is often rare compared to humans. In this study, the authors investigated the genetic basis of ocular squamous cell carcinoma (SCC). They were able to map a risk locus to ECA12, and to identify a missense mutation in DDB2, a UV-damage DNA repair enzyme. The human genetic disorder xeroderma pigmentosum complementation group E can also be explained by mutations in DDB2. These results should aid in detection and prognosis of ocular SCC in horses, and enable interspecies comparisons.
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horses were excluded if they were under the age of 13, one standard deviation above the mean age of diagnosis as reported in a previous study. 3 Bilateral photographs of 51 horses were used to phenotype for variation in shade of chestnut coloration and horses were classified as light, medium, or dark. Additionally, 66 horses were genotyped for the 20 Genomic DNA was extracted from blood or hair bulbs using the Puregene whole-blood extraction kit (Qiagen Inc., Valencia, CA) following the manufacture's protocol. A slight modification was used for hair bulb extraction. Specifically, 15-20 hair bulbs were placed in 300 mL of Puregene Cell Lysis Solution containing 0.003 mg of proteinase K (Sigma-Adrich) and incubated at 558C overnight. DNA was precipitated with 300 mL of isopropanol and resuspended in 60 mL of DNA Hydration Solution.
Pedigree analysis
To interrogate a recessive mode of inheritance, the pedigrees of 43 affected and 24 unaffected horses were examined. Four generation pedigrees were provided by horse owners and additional pedigree information was determined from the Haflinger breed registry website (http://www.haflingerhorse. com/pedigree/PedigreeVr2Pub.htm).
Pedigree analysis was performed using Pedigraph (http:// animalgene.umn.edu/pedigraph). A recessive mode of inheritance was investigated by extracting individual pedigrees of each of the affected horses to determine if the previously identified common ancestor (or one of his ancestors) could be found on both sides of the pedigree. Additionally, examination of the full extended pedigree identified the most informative half-sibling family and this was evaluated for several modes of inheritance.
Genome-wide association study genotyping and quality control Simple recessive traits in horses have been successfully mapped with small sample sizes, thus we employed a genome-wide association study (12 cases and 11 controls) using the available EquineSNP70 BeadChip (Illumina Inc., San Diego, CA). Genotyping was performed by GeneSeek (Neogen Inc., Lincoln, NE). To minimize population structure and maximize potential mapping success with this relatively small sample set, horses were selected for inclusion based on one degree of separation while also maximizing relatedness among cases and controls. Genomic inflation in this sample set was not detected (k 5 1.0). All genotyping data were analyzed and results visualized using Golden Helix SNP & Variation Suite (version 8.3.0, Golden Helix, Inc., Bozeman, MT www.goldenhelix.com). SNPs with a call-rate < 90% or minor allele frequency 0.05 were excluded, leaving 41,743 SNPs for analysis. LD decay was measured by calculating r 2 in adjacent SNP pairs using the expectationmaximization (EM) method.
Statistical testing, replication study, and fine mapping
To identify loci warranting further investigation, v 2 tests for basic allelic associations were performed. None of the associated loci reached a strict Bonferroni correction (1.20 3 10 26 ) in our small sample set, thus we also utilized a homozygosity mapping approach, appropriate for a simple recessive trait. Clusters of runs of homozygosity were defined as those runs detected in at least eight individuals with a minimum length of 15 SNPs, and allowing one missing and one heterozygous genotype within a single run. A Student's t test was applied to determine if homozygosity differed between cases and controls and a Bonferroni significance threshold for the number of detected clusters (310) was applied.
Replication testing was performed in 47 additional horses for the 17 most associated SNPs (P < 9.2 3 10
24
) from eight chromosome regions (Supporting Information, Table S1 ). Two SNPs were excluded for low call rates <90% (BIEC2_183197 and BIEC2_857901). Seven SNPs from the GWAS data set plus an additional 66 markers were genotyped to refine the risk locus on ECA12 (Supporting Information, Table S2 ). Whole-genome sequence data was available from one Haflinger horse with unknown limbal SCC phenotype and was evaluated for unique SNPs (https:/www.ncbi.nlm.nih.gov/sra/?term5SAMEA4075260). A total of 2754 variants in the region of interest (ECA12: 10.8-12.1 Mb) were identified. After filtering, using 52 sequenced controls of various other horse breeds, 19 variants remained. Forty-seven additional variants were selected from publically available SNP data in other breeds (http://archive.broadinstitute. org/ftp/distribution/horse_snp_release/v2/). The panel included at least one SNP per gene from the associated 1.5 Mb locus. After filtering for missingness (call rates <90%) and those with minor allele frequencies 0.05, 42 polymorphisms remained. SNPs for replication testing and fine mapping were genotyped with the Agena MassARRAY spectrophotometry platform and v 2 tests of association were calculated.
To determine if a single haplotype was more associated than any variant, measures of linkage disequilibrium between markers (r 2 ) in the ECA12 locus were calculated and haplotype blocks were computed using the Golden Helix SNP and Variation Suite default parameters. Each of the three blocks detected were analyzed for association by v 2 testing. Several of the samples in the final set (N 5 67) were half siblings, to correct for relatedness, a random resampling approach was employed in which one member from each half sib family was randomly selected (N 5 48) for 50 iterations. The v 2 statistics were calculated for each iteration and then the mean of these iterations were computed. The v 2 for all samples and for the mean of the resampling approach are reported.
To fine map the risk locus, we manually examined the haplotypes of all 30 affected horses. We identified the most common haplotype in which the majority of our affected horses were homozygous. We then identified recombination as the position in the haplotype where at least one case no longer had an SCC major allele and heterozygosity continued in this individual for at least 100 kb or the position at which multiple cases were no longer homozygous for the SCC major allele.
Candidate gene sequencing DDB2: SNP identification and investigation
Sanger sequencing of one affected and two control horses was performed for all 10 exons and flanking intron sequence of DDB2. Exon and intron structure for the horse was determined from the Ensembl database (transcript ID: ENSE-CAT00000009017.1). Primer sequences, amplicon size, and PCR conditions are reported in Supporting Information, Table S3 . Standard PCR protocol was performed using 0.1 U of FastStartTaq DNA polymerase (Roche Applied Science Indianapolis, IN, USA). Amplicons were purified using EdgeBio Quickstep 2 PCR purification kit following the manufactures protocol (EdgeBio, Gaithersburg, MD, USA) and subsequently sequenced using BigDye Terminator v3.1 and ABI 3730 Genetic Analyzer(Applied Biosystems, at ThermoFisher Scientific, Grand Island, NY, USA). The sequencing data were compared to the horse reference genome using BLAT at UCSC Genome Browser (http://genome.ucsc.edu and analyzed with Sequencher version 5.2.4 (http://www. genecodes.com) to identifying variants.
Genotyping for the identified missense mutation (c.1013 C > T, p.Thr338Met) was performed by a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis using the enzyme BsaBI (New England Biolab Inc, Ipswich, MA, USA). Digested products were resolved with either agarose gel electrophoresis or capillary electrophoresis (using a 5 0 6-Fam labeled fluorescent PCR primer). Sixty-seven Haflingers with confirmed limbal SCC phenotypes were genotyped for this polymorphism. v 2 testing for a recessive model and relative risk calculations were performed. Additionally, to determine the frequency of this allele in the Haflinger and 12 other breeds, 1034 registered horses not examined for limbal SCC were genotyped.
The relationship between the breeds tested was determined using publically available SNP data (animalgenome.org). 27, 28 Autosomal SNPs with minor allele frequency >0.01, genotyping rate >95%, and with linkage disequilibrium (r 2 ) <0.2 were included in the analysis. Pairwise fixation indices (F ST ) values were calculated using Arlequin 29 and relationships were visualized with a neighbor joining tree constructed using Nei's distance based upon within breed allele frequencies of 17,601 autosomal loci in Phylip. 30 
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Computational investigation of DDB2 polymorphism
To determine if the Thr > Met substitution was deleterious, the amino acid sequence for this protein was compared across all vertebrates using the data available from UCSC genome browser (https://genome.ucsc.edu). Furthermore, the consensus classifier Predict SNP was utilized to determine if this was a neutral or deleterious substitution. 31 The X-ray crystal structure of human DDB2 protein (accession number 4E5Z), complexed with DDB1 and a synthetic 24 bp DNA substrate with a central abasic site to mimic UV damage, was downloaded from the Protein Data Bank. 32 This structure was visualized and the mutation modeled using Swiss-PdbViewer (DeepView) Version 4.1 (http:// www.expasy.org/spdbv/). 33 Taking into account the bond distance of most interactions that stabilize protein tertiary structure and the resolution of this X-ray diffraction experiment (3.22 Å), the interactions of residue 338 with those residues within six angstroms were considered.
Results
Pedigree and coat color analysis
Examination of the pedigrees from 43 affected individuals supported a simple recessive mode of inheritance (Fig. 2) . Out of 43 affected horses, 38 traced back on both sides of the pedigree to the common ancestor previously identified. 3 The five remaining horses traced back on both sides to this ancestor's grandsire. However, the strongest support for a recessive mode of inheritance is exemplified from an extended half sib family, the sire (horse HF-12-06; Fig. 2b ) first examined at age 18 and then reexamined at age 22, was free of any signs of SCC. Three of his seven offspring were affected while the other four were unaffected. When bred to two affected females, both an affected and an unaffected horse were documented. Taken together, this supports the notion that this sire is a carrier for a recessive risk factor. Furthermore, based on our analysis, the sire of HF-12-06, produced affected (N 5 2) and unaffected individuals (N 5 2) suggesting that he was also heterozygous for a recessive risk factor (Fig. 2b) . When examining the horses for variation in shade of chestnut coloration, we identified 8 light, 24 medium, and 19 dark shade horses. The genetic cause of shade variation is unknown; however, no significant association was detected with shade and limbal SCC status (P 5 0.43). As expected, the population was fixed for the MC1R chestnut allele (e). This population did not show variation in 15 additional coat color loci. Four coat color loci were however polymorphic in this sample set, but a significant association with cancer status was not detected (Supporting Information, Table S4 )
Genome-wide association study
Linkage disequilibrium (LD) decay was comparable to other horse breeds as reported in Petersen et al. (2013) (Supporting  Information, Fig. S1 ). 27 Given this LD measure and the identified recessive mode of inheritance, the SNP density of the EquineSNP70 chip should provide adequate power to detect a major locus of significance from genotypes of 23 Haflinger horses with well-classified phenotypes. While none of the associated loci reached a strict Bonferroni correction for multiple testing (P 1.20 3 10
26
) we identified eight loci (one on ECA 4, 7, 9, 12, and two each on ECA1 and ECAX) warranting further investigation (P 9.21 3 10
24
, Fig. 3a and Supporting Information, Table S1 ). When a Cancer Genetics and Epigenetics homozygosity mapping approach was employed, only the locus on ECA12 was significantly associated after correction for multiple testing (P corrected 5 0.04, Fig. 3b) . To test the hypothesis that a locus on ECA12 contributes to genetic risk for limbal SCC while the other associated loci were false positives, 17 markers from these eight chromosome regions were genotyped in a second sample set consisting of 47 horses (21 cases and 26 controls). Replication testing supported our hypothesis, only SNPs on ECA12 were more significantly associated in this sample set (P 5 2.55 3 10
27
; Fig. 3c and Supporting Information, Table S1 ).
Mutational discovery and association testing
The 1.5 Mb associated locus on ECA12 contains 37 genes, eight were considered functional candidates being implicated in various types of carcinoma or in vascularization (Supporting Information, Table S5 ). One of these, Damaged DNAbinding Protein 2 (DDB2), stimulates the repair of UV induced DNA damage, specifically cyclobutane pyrimidine dimers (CPD) and 6-4 pyrmidine-pyrimidone lesions (6-4PP). 34 Because UV damage was previously implicated as a risk factor for ocular SCC in horses, 10 this gene was further investigated. The sequence of exons and flanking introns was examined and 12 novel polymorphisms were detected (Supporting Information, Table S3 ). Six were found in all three Haflingers sequenced when compared to the horse reference genome (equCab2), these may represent Haflinger specific variants but they were not investigated further. For five variants, the case genotype matched that of the horse reference genome (a Thoroughbred not known to have ocular SCC), thus excluding these as causative. A novel nonsynonymous mutation was identified in exon 7 of this gene (c.1013 C > T) and fit a recessive model for cancer risk (Supporting Information, Figs. S2 and S3 ). The case sample was homozygous for the T allele, one control was heterozygous, and the other control was homozygous for the reference C allele. Genotyping this SNP in available samples with known phenotypes (N 5 67) detected a strong but not perfect association for this variant, explaining 77% of the cases (P 5 3.41 3 10 210 ;
Supporting Information, Table S6 ). Haflingers homozygous for the T allele had 5.89 times the risk of developing limbal SCC than horses whose genotypes are T/C or C/C.
Fine mapping and haplotype analysis
Single marker and haplotype association testing using genotypes from 42 markers in 67 horses did not identify another SNP or haplotype that were more strongly associated than the DDB2 exon 7 SNP (c.1013 C > T; Fig. 4 ). Utilizing the mean values from 50 iterations of random resampling confirmed this marker as the most associated (P 5 7.97 3 10
28
, Fig. 4 ).
There was one SNP (LSCC35) in perfect linkage disequilibrium with the DDB2 exon 7 variant. This SNP is predicted to be in an intron of an unannotated gene. In humans, it is characterized as chromosome 11 open reading frame 49 (C11orf49) but the function remains unknown. This variant cannot be excluded as causative; however, given that the LSCC35 variant likely occurs in an intron, we did not investigate it further.
Examining haplotypes of horses homozygous for the most associated variant (c.1013 C > T) helped refine the location of the SCC genetic risk factor on ECA12 from a 1.5 Mb interval to 483 kb. All but seven of these were homozygous for the case major allele across the entire locus; these seven narrowed our critical interval (Supporting Information, Table  S7 ). Specifically, three horses showed haplotypes with the SCC case minor alleles beginning at LSCC30 and extending 5 0 and one additional horses was homozygous for case minor alleles beginning at LSCC 30 (Fig. 4) . A recombination event was also identified in one individual (HF-13-25) at LSCC50 (Chr12: 11,767,256) with a haplotype containing case minor alleles that extended 187 kb 3 0 (Fig. 4b and Supporting Information, Table S7 ).
Investigating other breeds for the DDB2 exon 7 (c.1013 C > T) mutation
To further investigate the DDB2 SNP as a causative risk allele, we examined allele frequencies in 13 breeds with reported cases of ocular SCC ( Table 1 ). The associated allele (T) was only detected in three of these breeds with 19 out of 1034 horses examined homozygous for this allele. The majority of the homozygotes were from the Haflinger breed (17 out of 19), while two were Belgian horses. The frequency of the risk allele was 0.25 in Haflinger. The Belgian breed had a similar allele frequency (0.21) and the next highest frequency was in the Percheron breed (0.07). Investigating available GWAS data across these breeds suggests that Haflingers, Belgians, and Percherons show a close genetic relationship (Supporting Information, Fig. S4 ). This was supported by pairwise F ST for Haflinger and Belgian of 0.093 and 0.084 between the Haflinger and Percheron. These were among the lowest for all comparisons, with pairwise F ST values including the Haflinger ranging from 0.084 (with the Percheron) to 0.176 (with the Clydesdale).
Computational investigation of DDB2 polymorphism Thr338Met
Examining the protein sequence of DDB2 across 95 vertebrate species showed that threonine at amino acid 338 is perfectly conserved. The Thr338Met substitution was predicted to be "deleterious" by the consensus classifier Predict SNP with a confidence score of 76% and "probably damaging" with a score of 1.00 based on the PolyPhen-2 prediction. DDB2 is composed of an N-terminal alpha paddle domain that is followed by a seven-bladed WD40 b-propeller domain. Thr 338 is located in the b-loop between strand five and six of the b-propeller domain. This loop comprises one of the four distinct regions of contact between damaged DNA and DDB2 and recognizes UV-damaged DNA in a sequence-independent manner. 32 Specifically, highly conserved residues-His333, Phe334, Gln335 and His336-insert into the minor groove and contact the bases on the opposite strand. The binding of DDB2 to DNA causes a major distortion of DNA that is stabilized by electrostatic interactions between positively charged amino acids of DDB2 and the phosphate backbone of the two nucleotides upstream and downstream of the lesion. 32 Computational modeling predicts that Threonine 338 forms hydrogen bonds with Arginine 113 Total 1034 1 Haflinger sample set is composed of horses from both the American population and that of Austria.
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and Alanine 114, located in the first b-strand. Substituting the polar threonine for the nonpolar methionine would no longer allow hydrogen bonding to occur and could cause steric effects that alter the proper formation of the tertiary structure (Fig. 5) . Furthermore, Arginine 112, also located in the first b-strand, is one of the three amino acids shown to form electrostatic interactions with the distorted DNA. Thus, we propose that a substitution of threonine for methionine at residue 338 affects the ability of DDB2 to bind to and recognize UV-damaged DNA by hindering two of the four primary contacts needed for damage recognition.
Discussion
Here we show that a genetic risk factor for limbal SCC in Haflinger horses is best explained by a recessive mode of inheritance. We mapped a major risk locus to a 483 kb region of ECA12. The most physiologically relevant candidate gene from this region, DDB2, is involved in global genomic nucleotide excision repair. DDB2 binds and recognizes DNA that contains helical distortions caused by UV-induced CPD. 34 Upon binding damaged DNA, DDB2, part of a multiprotein complex, causes ubiquitination of core histones, other proteins, and itself. 35, 36 This results in the replacement of DDB2 with XPC at the lesion site, beginning the repair process. [37] [38] [39] We identified one missense mutation (c.1013 C > T, p.Thr338Met) that was computationally predicted to be deleterious to photolesion recognition. Future work will aim to test this hypothesis further by performing DNA repair function assays in cells with and without the identified variant. However, mutations in DDB2 have been shown to cause xeroderma pigmentosum (XP) complementation group E (XP-E) in humans. XP is also a recessive disorder that encompasses eight complementation groups (XP-A thru XP-G and XP-V). 40 Clinical manifestations of XP-E are thought to be milder than the other forms of XP and include sensitivity to UV light without accompany neurological defects. To date, in humans, 12 different mutations causing XP-E have been identified in DDB2, five of which involve exon 7, the exon containing the horse mutation, providing further support that this region is critical for protein function. 41 Human patients with DDB2 mutations have multiple occurrences of carcinomas of the skin including basal cell carcinoma, melanoma and squamous cell carcinoma. However, to our knowledge, none has been directly linked to a higher incidence of ocular SCC. In one study, 91% of XP patients, encompassing complementation groups A-G, were reported to have at least one ocular abnormality. Nine of these patients were diagnosed with ocular cancer (melanoma, BCC and SCC) but XP complementation groups were not specifically reported. 42 Similarly, none of the Haflinger cases in our study were known to have cutaneous neoplasms that did not involve ocular tissue. Thus, DDB2's role in DNA repair may differ between mammals. Differences in transcript abundance and regulation have been observed between mouse and humans.
40 DDB2 transcription in humans is controlled by the tumor suppressor p53, a transcription factor that responds to UV DNA damage and other cellular stresses. However, in mice, DDB2 is normally expressed at low levels and is regulated by the transcription factor E2F. [43] [44] [45] Further, recent work in humans to investigate why UV-induced cancer is less frequently found in the cornea when compared to the skin, identified corneal cells as having a 4 times faster CPD repair than epidermal cells. Investigating the key proteins involved in repair of CPD has shown that although RNA levels are lower for DDB2 and XPC in corneal epithelial cells compared to epidermal cells, there was an increased stability of DDB2, XPC, and p53 proteins in corneal cells. 46 As horses evolved as prey animals and rely heavily on their vision, with the largest globe of all land mammals, it is possible that DDB2 is critical in this species for UV-damage detection in ocular tissues and that pigmented hair protects most of the other sun-exposed surfaces. It is unknown if p53 or E2F regulates DDB2 in the horse and if this regulation can help to clarify the connection to p53 overexpression in some equine ocular SCC observed. 12 Furthermore, the relative DDB2 transcript and protein levels in equine skin and ocular tissues, and comparisons to human and mouse, remains to be evaluated. The identified mutation in DDB2 was the most significantly associated marker from this region but was not perfectly associated with limbal SCC in Haflinger horses. One control sample, homozygous for the risk allele (T), was unaffected at age 17 and was free of any signs of ocular lesions when reexamined at age 20. It is possible that this horse has been protected from UV-radiation for example by being stalled during daylight hours. It is also possible that the mutation in DDB2 is not the causal variant, although this horse was homozygous for case major alleles across the entire ECA12 interval evaluated, making the former hypothesis more likely. Investigating the sequence by next generation sequencing methodology for the entire 483 kb haplotype is warranted to definitively rule out yet-unknown variants from this locus.
Seventy-seven percent of our cases can be explained by the variant in DDB2. The seven affected horses that were not homozygous for the DDB2 risk allele also did not have runs of homozygosity for case major alleles. It is also possible that these exceptional cases can be explained by other inherited and/or environmental risk factors. If the inherited component involves multiple genes, loci of small effect could have been missed with the sample set used in our GWAS.
Chestnut coat color was previously implicated as a risk factor, thus absence of eumelanin production may explain the other 23% of our cases, either directly by pheomelanin being less photoprotective or through the disruption of molecular pathways caused by absence of signaling through MC1R. 17, 18, 20 Loss of function mutations in MC1R delays repair of CPD in human melanocytes and fails to activate p53 and p38 in co-cultures of melanocytes and keratinocytes. 47 p38 is involved in recruiting XPC and mediating degradation of DDB2, thus showing a connection between MC1R signaling and UV-damage DNA repair. It is possible that paracrine interactions, or absence thereof, between melanocyte signaling and keratinocytes may help to explain some forms of ocular SCC, for example, those on the eyelids. There are no studies that have characterized melanocytes in horse limbal tissue. In human cornea, melanocytes have only been detected in the periphery of the limbal epithelium and melanocytes and epithelial cells of the limbus may form a functional network similar to the melanin unit of the skin. 48 The paracrine interaction between melanocytes and neighboring cells has not been studied in the horse and how the loss of function mutation in MC1R increases risk for ocular SCC should be further investigated. It is possible that other coat color loci could also explain the genetic risk in this breed; however, no trends were observed when coat color phenotypes and genotypes of the seven horses not homozygous for the risk allele were evaluated.
The identified DDB2 missense mutation, found in the Haflinger breed, was also present with similar allele frequencies in the Belgian horse breed and to a lesser extent in Percherons. These three breeds appear to be closely related. The phenotype for ocular SCC was not known for the Belgian and Percheron samples used in this study but both breeds have reported cases of ocular SCC and therefore this polymorphism in DDB2 may also be a risk factor in these closely related breeds. Furthermore, as Haflinger horses present with SCC on the third eyelid, determining if this variant explains the genetic risk for this cancer is also warranted.
Ocular SCC in the horse is similar to that in humans as it can be locally invasive and has variable rates of reoccurrence (as high as 67% in horse compared to 21% in humans). 6, 49 However, rates of metastasis to regional lymph nodes are reported as rare in humans (<1%) but appear to be more variable in the horse, up to 18% in one study. 9, 49 Even though these similarities exist, and despite this cancer being the second most common tumor of the horse, this work represents the first study to investigate a molecular genetic component in horse. Here we identified a risk locus, namely DDB2, which causes xeroderma pigmentosum and increased risk of cutaneous SCC in humans. Mutated DDB2 may lead to increased risk for neoplasms that differ by location in humans and horses. For future studies, we aim to further characterize the functional role of this mutation, DDB2 transcriptional activation, and protein stabilization in the horse to more clearly delineate the role of this important DNA repair protein in these two species, among others. We also plan to investigate and identify other potential genetic risk loci in the horse which should also help to make crossspecies comparisons possible. Unraveling the molecular genetic components of SCC in horses should aid in the understanding of the biology of this cancer and help to better understand properties related to invasiveness and metastasis, thus identifying better therapeutic targets and precautionary measures to save vision, lower recurrence rates, and identify individuals at highest risk before tumors occur.
